Model Number FT3 G3 |
Device Problems
Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 01/26/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
This event occurred in (b)(6).Unique identifier (udi): (b)(4).
|
|
Event Description
|
The initial reporter questioned results for 1 patient sample tested for elecsys ft3 iii (ft3 iii) on a cobas e801 module.The questionable results were reported outside of the laboratory where the physician requested additional testing.The sample was submitted for investigation where discrepant results were identified between the customer¿s e801 module, the siemens centaur method, an e801 module used at the investigation site, a cobas 8000 e 602 module used at the investigation site and a cobas e 411 immunoassay analyzer used at the investigation site.Refer to the attached data for the patient results.The serial number for the customer¿s e801 module was not provided.The e602 serial number was (b)(4).The e411 serial number was (b)(4).The e801 module serial number used at the investigation site was (b)(4).The ft3 iii reagent lot number used with the e602 module and the e411 analyzer was 473372 with an expiration date of 31-may-2021.The ft3 iii reagent lot number used with the e801 module at the investigation site was 476059 with an expiration date of 31-aug-2021.
|
|
Manufacturer Narrative
|
The sample was submitted for further investigation.Based on the results received during the investigation, an interferent was not identified.The investigation found the reagent meets specifications.There was no device problem found.
|
|
Manufacturer Narrative
|
The customer's e801 module serial number was (b)(6).
|
|
Manufacturer Narrative
|
A new sample was obtained from the patient on (b)(6)-2022.No results from the customer site were provided for this sample.The sample was submitted for investigation where discrepant results were identified for ft3 iii between the e801 module at the investigation site and the abbott architect method.Refer to the attached data for the patient results.The ft3 iii reagent lot number used with the e801 module at the investigation site was 551720 with an expiration date of 30-sep-2022.Section b6 was updated.The investigation is ongoing.
|
|
Manufacturer Narrative
|
The sample from (b)(6) 2022 was investigated further.The ft3 result was reproduced.Interference testing was performed and no interfering factors were identified.Assays from different manufacturers can generate different results.This relates to the overall setups of the assays, the antibodies used, differences in reference materials, and the standardization methodology used.Based on the information provided, a general reagent issue can be excluded.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination, and other findings.The investigation did not identify a product problem.
|
|
Search Alerts/Recalls
|